Using data and AI to accelerate innovation in Pharma

The Pharmaceutical industry works on some of the toughest scientific problems in existence. AI can provide great benefits in terms of speed and R&D productivity; but what about the risks? Elsevier has put AI to work across multiple drug discovery problems, deploying different technologies and approaches. Mirit Eldor, Managing Director of the Life Sciences business, will share key lessons learned along the way.